139 related articles for article (PubMed ID: 38590263)
1. Low-Dose Infigratinib Increases Bone Growth And Corrects Growth Plate Abnormalities In An Achondroplasia Mouse Model.
Demuynck B; Flipo J; Kaci N; Dambkowski C; Paull M; Muslimova E; Shah BP; Legeai-Mallet L
J Bone Miner Res; 2024 Apr; ():. PubMed ID: 38590263
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model.
Komla-Ebri D; Dambroise E; Kramer I; Benoist-Lasselin C; Kaci N; Le Gall C; Martin L; Busca P; Barbault F; Graus-Porta D; Munnich A; Kneissel M; Di Rocco F; Biosse-Duplan M; Legeai-Mallet L
J Clin Invest; 2016 May; 126(5):1871-84. PubMed ID: 27064282
[TBL] [Abstract][Full Text] [Related]
3. Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies.
Savarirayan R; De Bergua JM; Arundel P; McDevitt H; Cormier-Daire V; Saraff V; Skae M; Delgado B; Leiva-Gea A; Santos-Simarro F; Salles JP; Nicolino M; Rossi M; Kannu P; Bober MB; Phillips J; Saal H; Harmatz P; Burren C; Gotway G; Cho T; Muslimova E; Weng R; Rogoff D; Hoover-Fong J; Irving M
Ther Adv Musculoskelet Dis; 2022; 14():1759720X221084848. PubMed ID: 35342457
[TBL] [Abstract][Full Text] [Related]
4. Infigratinib, a selective FGFR1-3 tyrosine kinase inhibitor, alters dentoalveolar development at high doses.
Michel ZD; Aitken SF; Glover OD; Alejandro LO; Randazzo D; Dambkowski C; Martin D; Collins MT; Somerman MJ; Chu EY
Dev Dyn; 2023 Dec; 252(12):1428-1448. PubMed ID: 37435833
[TBL] [Abstract][Full Text] [Related]
5. Maternal administration of meclozine for the treatment of foramen magnum stenosis in transgenic mice with achondroplasia.
Matsushita M; Mishima K; Esaki R; Ishiguro N; Ohno K; Kitoh H
J Neurosurg Pediatr; 2017 Jan; 19(1):91-95. PubMed ID: 27767902
[TBL] [Abstract][Full Text] [Related]
6. Circulatory CNP Rescues Craniofacial Hypoplasia in Achondroplasia.
Yamanaka S; Nakao K; Koyama N; Isobe Y; Ueda Y; Kanai Y; Kondo E; Fujii T; Miura M; Yasoda A; Nakao K; Bessho K
J Dent Res; 2017 Dec; 96(13):1526-1534. PubMed ID: 28644737
[TBL] [Abstract][Full Text] [Related]
7. New developments in the management of achondroplasia.
Högler W; Ward LM
Wien Med Wochenschr; 2020 Apr; 170(5-6):104-111. PubMed ID: 32144686
[TBL] [Abstract][Full Text] [Related]
8. C-Type Natriuretic Peptide Analog as Therapy for Achondroplasia.
Legeai-Mallet L
Endocr Dev; 2016; 30():98-105. PubMed ID: 26684019
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Imaging of the Skull Base Synchondroses Demonstrate Prevention of a Premature Ossification After Recifercept Treatment in Mouse Model of Achondroplasia.
Rignol G; Garcia S; Authier F; Smith K; Tosello L; Marsault R; Dellugat P; Goncalves D; Brouillard M; Stavenhagen J; Santarelli L; Czech C; Gouze E
JBMR Plus; 2022 Feb; 6(2):e10568. PubMed ID: 35229060
[TBL] [Abstract][Full Text] [Related]
10. Long-term oral meclozine administration improves survival rate and spinal canal stenosis during postnatal growth in a mouse model of achondroplasia in both sexes.
Funahashi H; Matsushita M; Esaki R; Mishima K; Ohkawara B; Kamiya Y; Takegami Y; Ohno K; Kitoh H; Imagama S
JBMR Plus; 2024 Apr; 8(4):ziae018. PubMed ID: 38544920
[TBL] [Abstract][Full Text] [Related]
11. Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1-3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3-altered Advanced/Metastatic Urothelial Carcinoma.
Lyou Y; Grivas P; Rosenberg JE; Hoffman-Censits J; Quinn DI; P Petrylak D; Galsky M; Vaishampayan U; De Giorgi U; Gupta S; Burris H; Rearden J; Li A; Wang H; Reyes M; Moran S; Daneshmand S; Bajorin D; Pal SK
Eur Urol; 2020 Dec; 78(6):916-924. PubMed ID: 32847703
[TBL] [Abstract][Full Text] [Related]
12. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3.
Naski MC; Colvin JS; Coffin JD; Ornitz DM
Development; 1998 Dec; 125(24):4977-88. PubMed ID: 9811582
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Lorget F; Kaci N; Peng J; Benoist-Lasselin C; Mugniery E; Oppeneer T; Wendt DJ; Bell SM; Bullens S; Bunting S; Tsuruda LS; O'Neill CA; Di Rocco F; Munnich A; Legeai-Mallet L
Am J Hum Genet; 2012 Dec; 91(6):1108-14. PubMed ID: 23200862
[TBL] [Abstract][Full Text] [Related]
14. Aspects of achondroplasia in the skulls of dwarf transgenic mice: a cephalometric study.
Bloom MW; Murakami S; Cody D; Montufar-Solis D; Duke PJ
Anat Rec A Discov Mol Cell Evol Biol; 2006 Mar; 288(3):316-22. PubMed ID: 16463380
[TBL] [Abstract][Full Text] [Related]
15. Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth.
Shuhaibar LC; Kaci N; Egbert JR; Horville T; Loisay L; Vigone G; Uliasz TF; Dambroise E; Swingle MR; Honkanen RE; Biosse Duplan M; Jaffe LA; Legeai-Mallet L
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986191
[TBL] [Abstract][Full Text] [Related]
16. Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia.
Martin L; Kaci N; Estibals V; Goudin N; Garfa-Traore M; Benoist-Lasselin C; Dambroise E; Legeai-Mallet L
Hum Mol Genet; 2018 Jan; 27(1):1-13. PubMed ID: 29040558
[TBL] [Abstract][Full Text] [Related]
17. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.
Matsushita T; Wilcox WR; Chan YY; Kawanami A; Bükülmez H; Balmes G; Krejci P; Mekikian PB; Otani K; Yamaura I; Warman ML; Givol D; Murakami S
Hum Mol Genet; 2009 Jan; 18(2):227-40. PubMed ID: 18923003
[TBL] [Abstract][Full Text] [Related]
18. Meckel's and condylar cartilages anomalies in achondroplasia result in defective development and growth of the mandible.
Biosse Duplan M; Komla-Ebri D; Heuzé Y; Estibals V; Gaudas E; Kaci N; Benoist-Lasselin C; Zerah M; Kramer I; Kneissel M; Porta DG; Di Rocco F; Legeai-Mallet L
Hum Mol Genet; 2016 Jul; 25(14):2997-3010. PubMed ID: 27260401
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains.
Wang Q; Green RP; Zhao G; Ornitz DM
Development; 2001 Oct; 128(19):3867-76. PubMed ID: 11585811
[TBL] [Abstract][Full Text] [Related]
20. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.
Wang Y; Spatz MK; Kannan K; Hayk H; Avivi A; Gorivodsky M; Pines M; Yayon A; Lonai P; Givol D
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4455-60. PubMed ID: 10200283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
